カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Equine Rabies Immunoglobulin (ERIG) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19298）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19298
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ウマ狂犬病免疫グロブリン（ERIG）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のウマ狂犬病免疫グロブリン（ERIG）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ウマ狂犬病免疫グロブリン（ERIG）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・1500IU、1000IU、400IU、その他

用途別セグメントは次のように区分されます。
・カテゴリーⅡばく露、カテゴリーⅢばく露

世界のウマ狂犬病免疫グロブリン（ERIG）市場の主要な市場プレーヤーは以下のとおりです。
・Serum China、Lanzhou Institute of Biological Products、Wuhan Institute of Biological Products、Premium Serums、Haffkine Bio-Pharmaceutical、Bharat Serums

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ウマ狂犬病免疫グロブリン（ERIG）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なウマ狂犬病免疫グロブリン（ERIG）メーカーの企業概要、2019年～2022年までのウマ狂犬病免疫グロブリン（ERIG）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なウマ狂犬病免疫グロブリン（ERIG）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ウマ狂犬病免疫グロブリン（ERIG）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのウマ狂犬病免疫グロブリン（ERIG）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのウマ狂犬病免疫グロブリン（ERIG）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびウマ狂犬病免疫グロブリン（ERIG）の産業チェーンを掲載しています。
・第13、14、15章では、ウマ狂犬病免疫グロブリン（ERIG）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ウマ狂犬病免疫グロブリン（ERIG）の概要
- 種類別分析（2017年vs2021年vs2028年）：1500IU、1000IU、400IU、その他
- 用途別分析（2017年vs2021年vs2028年）：カテゴリーⅡばく露、カテゴリーⅢばく露
- 世界のウマ狂犬病免疫グロブリン（ERIG）市場規模・予測
- 世界のウマ狂犬病免疫グロブリン（ERIG）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Serum China、Lanzhou Institute of Biological Products、Wuhan Institute of Biological Products、Premium Serums、Haffkine Bio-Pharmaceutical、Bharat Serums
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：1500IU、1000IU、400IU、その他
・用途別分析2017年-2028年：カテゴリーⅡばく露、カテゴリーⅢばく露
・ウマ狂犬病免疫グロブリン（ERIG）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ウマ狂犬病免疫グロブリン（ERIG）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ウマ狂犬病免疫グロブリン（ERIG）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ウマ狂犬病免疫グロブリン（ERIG）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ウマ狂犬病免疫グロブリン（ERIG）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Equine Rabies Immunoglobulin (ERIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Equine Rabies Immunoglobulin (ERIG) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Category II Exposure accounting for % of the Equine Rabies Immunoglobulin (ERIG) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 1500IU segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Equine Rabies Immunoglobulin (ERIG) include Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, and Haffkine Bio-Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Equine Rabies Immunoglobulin (ERIG) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
1500IU
1000IU
400IU
Other
Market segment by Application can be divided into
Category II Exposure
Category III Exposure
The key market players for global Equine Rabies Immunoglobulin (ERIG) market are listed below:
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Rabies Immunoglobulin (ERIG) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Rabies Immunoglobulin (ERIG), with price, sales, revenue and global market share of Equine Rabies Immunoglobulin (ERIG) from 2019 to 2022.
Chapter 3, the Equine Rabies Immunoglobulin (ERIG) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Rabies Immunoglobulin (ERIG) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Equine Rabies Immunoglobulin (ERIG) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Equine Rabies Immunoglobulin (ERIG).
Chapter 13, 14, and 15, to describe Equine Rabies Immunoglobulin (ERIG) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Equine Rabies Immunoglobulin (ERIG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size & Forecast
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume (2017-2028)
1.4.3 Global Equine Rabies Immunoglobulin (ERIG) Price (2017-2028)
1.5 Global Equine Rabies Immunoglobulin (ERIG) Production Capacity Analysis
1.5.1 Global Equine Rabies Immunoglobulin (ERIG) Total Production Capacity (2017-2028)
1.5.2 Global Equine Rabies Immunoglobulin (ERIG) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Equine Rabies Immunoglobulin (ERIG) Market Drivers
1.6.2 Equine Rabies Immunoglobulin (ERIG) Market Restraints
1.6.3 Equine Rabies Immunoglobulin (ERIG) Trends Analysis
2 Manufacturers Profiles
2.1 Serum China
2.1.1 Serum China Details
2.1.2 Serum China Major Business
2.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Product and Services
2.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lanzhou Institute of Biological Products
2.2.1 Lanzhou Institute of Biological Products Details
2.2.2 Lanzhou Institute of Biological Products Major Business
2.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
2.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Wuhan Institute of Biological Products
2.3.1 Wuhan Institute of Biological Products Details
2.3.2 Wuhan Institute of Biological Products Major Business
2.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
2.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Premium Serums
2.4.1 Premium Serums Details
2.4.2 Premium Serums Major Business
2.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
2.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bharat Serums
2.6.1 Bharat Serums Details
2.6.2 Bharat Serums Major Business
2.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
2.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Equine Rabies Immunoglobulin (ERIG) Breakdown Data by Manufacturer
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Equine Rabies Immunoglobulin (ERIG)
3.4 Market Concentration Rate
3.4.1 Top 3 Equine Rabies Immunoglobulin (ERIG) Manufacturer Market Share in 2021
3.4.2 Top 6 Equine Rabies Immunoglobulin (ERIG) Manufacturer Market Share in 2021
3.5 Global Equine Rabies Immunoglobulin (ERIG) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Equine Rabies Immunoglobulin (ERIG) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Region (2017-2028)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2028)
4.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
4.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
4.4 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
4.5 South America Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
4.6 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Type (2017-2028)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Application (2017-2028)
6.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
6.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
7.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
7.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Country (2017-2028)
7.3.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
8.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
8.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
8.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Country (2017-2028)
8.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
9.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
9.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Region
9.3.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
10.2 South America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
10.3 South America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
10.3.1 South America Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Country (2017-2028)
10.3.2 South America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
11.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
11.3 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country
11.3.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Equine Rabies Immunoglobulin (ERIG) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Equine Rabies Immunoglobulin (ERIG)
12.3 Equine Rabies Immunoglobulin (ERIG) Production Process
12.4 Equine Rabies Immunoglobulin (ERIG) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Equine Rabies Immunoglobulin (ERIG) Typical Distributors
13.3 Equine Rabies Immunoglobulin (ERIG) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Serum China Basic Information, Manufacturing Base and Competitors
Table 4. Serum China Major Business
Table 5. Serum China Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 6. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 8. Lanzhou Institute of Biological Products Major Business
Table 9. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 10. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 12. Wuhan Institute of Biological Products Major Business
Table 13. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 14. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Premium Serums Basic Information, Manufacturing Base and Competitors
Table 16. Premium Serums Major Business
Table 17. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 18. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Haffkine Bio-Pharmaceutical Major Business
Table 21. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 22. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bharat Serums Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Serums Major Business
Table 25. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 26. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Equine Rabies Immunoglobulin (ERIG), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Equine Rabies Immunoglobulin (ERIG) Production Site of Key Manufacturer
Table 32. Equine Rabies Immunoglobulin (ERIG) New Entrant and Capacity Expansion Plans
Table 33. Equine Rabies Immunoglobulin (ERIG) Mergers & Acquisitions in the Past Five Years
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)
Table 35. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (K Units)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 51. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 52. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 55. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 56. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 57. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 58. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 59. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 60. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 63. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 64. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 65. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 74. South America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 75. South America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 76. South America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 79. South America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 80. South America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 81. South America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 90. Equine Rabies Immunoglobulin (ERIG) Raw Material
Table 91. Key Manufacturers of Equine Rabies Immunoglobulin (ERIG) Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Equine Rabies Immunoglobulin (ERIG) Typical Distributors
Table 95. Equine Rabies Immunoglobulin (ERIG) Typical Customers
List of Figures
Figure 1. Equine Rabies Immunoglobulin (ERIG) Picture
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type in 2021
Figure 3. 1500IU
Figure 4. 1000IU
Figure 5. 400IU
Figure 6. Other
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application in 2021
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Sales (2017-2028) & (K Units)
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Price (2017-2028) & (US$/Unit)
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Production Capacity (2017-2028) & (K Units)
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Figure 17. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Figure 18. Equine Rabies Immunoglobulin (ERIG) Market Trends
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturer in 2021
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturer in 2021
Figure 21. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Equine Rabies Immunoglobulin (ERIG) Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Equine Rabies Immunoglobulin (ERIG) Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2028)
Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2028)
Figure 26. North America Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (USD Million)
Figure 27. Europe Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (USD Million)
Figure 29. South America Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (USD Million)
Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 33. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 36. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 38. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 39. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2028)
Figure 40. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2028)
Figure 41. United States Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 45. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2028)
Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2028)
Figure 57. China Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 64. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 65. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2028)
Figure 66. South America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG) in 2021
Figure 78. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 79. Equine Rabies Immunoglobulin (ERIG) Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）
  • 世界の狂犬病抗血清市場2022年：市場規模予測（～2028年）
  • 世界の牛胎児血清（FCS）市場2022年：市場規模予測（～2028年）
  • 世界のオクテニルコハク酸デンプンナトリウム（SSOS）市場2022年：市場規模予測（～2028年）
  • 世界のメチルシクロペンテノロン（MCP）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19298 )"世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）" (英文：Global Equine Rabies Immunoglobulin (ERIG) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。